Cumberland Pharmaceuticals (CPIX) Stock Statistics & Valuation Metrics

Cumberland Pharmaceuticals has a market cap or net worth of $44.73M. The enterprise value is $44.06M.

Cumberland Pharmaceuticals has 14,959,937 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cumberland Pharmaceuticals’s return on equity (ROE) is -0.28 and return on invested capital (ROIC) is -12.97%.

The current PE Ratio of Cumberland Pharmaceuticals is ―. Cumberland Pharmaceuticals’s PEG ratio is -1.13.

In the last 12 months, Cumberland Pharmaceuticals had revenue of 37.87M and earned -6.48M in profits. Earnings per share was -0.46.

In the last 12 months, operating cash flow was 7.12M and capital expenditures -60.11K, giving a free cash flow of 7.06M billion.

Cumberland Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Cumberland Pharmaceuticals upcoming earnings date is Nov 11, 2025, After Close (Confirmed).

Cumberland Pharmaceuticals as a current ratio of 1.15, with Debt / Equity ratio of 36.43%

In the past 12 months, Cumberland Pharmaceuticals has paid -22.67K in taxes.

Cumberland Pharmaceuticals EV to EBITDA ratio is 196.97, with an EV/FCF ratio of -45.37.

Cumberland Pharmaceuticals has $16.09M in cash and marketable securities with $10.34M in debt, giving a net cash position of -$5.75M billion.

Gross margin is 77.92%, with operating margin of -16.99%, and net profit margin of -17.11%.

The average price target for Cumberland Pharmaceuticals is $3.00, which is 11.43% higher than the current price. The consensus rating is Hold